OptiNose, Inc. announced preliminary XHANCE net product revenue results for the first quarter ended March 31, 2024. for the quarter, the company reported preliminary XHANCE net product revenue of $14.9 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 USD | -4.10% | +2.63% | -9.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.30% | 169M | |
+29.98% | 682B | |
+31.53% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.62% | 240B | |
+9.52% | 209B | |
-8.26% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- OPTN Stock
- News OptiNose, Inc.
- Optinose, Inc. Announces Preliminary XHANCE Net Product Revenue Results for the First Quarter Ended March 31, 2024